蛋白激酶A
化学
枸杞
癌症研究
磷酸肌醇3激酶
蛋白激酶C
多糖
细胞生物学
生物
信号转导
生物化学
激酶
医学
蛋白激酶B
病理
替代医学
作者
Songzhe Piao,Chaoqian Chen,Xin Wang,Licai Mo,Tao Hong,Mang Ke
标识
DOI:10.37290/ctnr2641-452x.19:295-302
摘要
Lycium barbarum is a boxthorn that produces the goji berries. L. barbarum polysaccharide is a water soluble bioactive component extracted from L. barbarum L. that has been shown to exert multiple pharmacological effects including antitumor effects. Herein, we have explored the mechanism underlying inhibition of tumor growth in J82 bearing bladder carcinoma by L. barbarum polysaccharides. The results of in vitro studies show that L. barbarum polysaccharide inhibited the expression of programmed death-ligand 1 protein, but not the gene transcription in bladder carcinoma cells. Also, L. barbarum polysaccharide decreased the level of phospho-protein kinase B/protein kinase B in cancer cells, and phosphoinositide- 3-kinase/protein kinase B pathway agonists reversed the inhibitory effect of L. barbarum polysaccharide on protein kinase B activation and programmed death-ligand 1 expression. Furthermore, when T cells and cancer cells were cultured together, treatments with either L. barbarum polysaccharide or antiprogrammed death-ligand 1 protein, enhanced T cell function including the expression of interferon-γ and interleukin-2 that were inhibited by phosphoinositide-3-kinase/protein kinase B pathway agonists. In conclusion, the results suggested that L. barbarum polysaccharide could inhibit programmed deathligand 1 expression via phosphoinositide-3-kinase/protein kinase B suppression of bladder cancer cells and further enhance the T-cell function in tumor microenvironment.
科研通智能强力驱动
Strongly Powered by AbleSci AI